n | dhfr mutations | dhps mutations | SP-IPTp efficacy outcome | ||||||
---|---|---|---|---|---|---|---|---|---|
51 | 59 | 108 | 437 | 540 | 581 | APR* | F†(R‡) | U§ | |
0 | – | – | – | – | – | – | N/A | N/A | N/A |
1 | – | – | + | – | – | – | 0 | 0 | 1 |
1 | – | + | + | – | – | – | 0 | 0 | 1 |
6 | – | + | + | + | + | – | 2 | 2 (1) | 2 |
1 | + | – | + | – | – | – | 1 | 0 | 0 |
1 | + | – | + | + | – | – | 0 | 0 | 1 |
1 | + | – | + | + | + | – | 1 | 0 | 0 |
17 | + | + | + | – | – | – | 11 | 1 | 5 |
2 | + | + | + | – | + | – | 1 | 0 | 1 |
1 | + | + | + | + | – | – | 0 | 1 (1) | 0 |
51 | + | + | + | + | + | – | 16 | 9 (4) | 26 |
2 | + | + | + | + | + | + | 2 | 0 | 0 |